Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015
Research

Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 31

Yuta Aizawa, Kanako Watanabe, Tomohiro Oishi, Harunobu Hirano, Isao Hasegawa, and Akihiko SaitohComments to Author 
Author affiliations: Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan (Y. Aizawa, T. Oishi, A. Saitoh); Niigata University Graduate School of Health Sciences, Niigata (K. Watanabe); Saiseikai Niigata Daini Hospital, Niigata (H. Hirano, I. Hasegawa); University of California San Diego School of Medicine, San Diego, California, USA (A. Saitoh)

Main Article

Figure 1

Distribution of neutralizing antibody titers to human parechovirus types 1, 3, and 6 in 175 cord blood samples from healthy neonates, Niigata, Japan, September 2013–January 2014. Titers are shown as reciprocal numbers. Boxes indicate first and third quartile values; bars within boxes indicate medians. Top and bottom bars indicate the 5th and 95th percentiles of data in a normal distribution. In the analysis, antibody titers of <1:4 and >1:2,048 were regarded as 1 and 2,048, respectively.

Figure 1. Distribution of neutralizing antibody titers to human parechovirus (HPeV) types 1, 3, and 6 in 175 cord blood samples from healthy neonates, Niigata, Japan, September 2013–January 2014. Titers are shown as reciprocal numbers. Boxes indicate first and third quartile values; bars within boxes indicate medians. Top and bottom bars indicate the 5th and 95th percentiles of data in a normal distribution. In the analysis, antibody titers <1:4 and >1:2,048 were regarded as 1 and 2,048, respectively.

Main Article

1Presented in part at IDWeek, October 8–12, 2014, Philadelphia, Pennsylvania, USA.

Page created: October 16, 2015
Page updated: October 16, 2015
Page reviewed: October 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external